Medical/Pharmaceuticals
Formosa Pharmaceuticals and AimMax Therapeutics to Present Phase 2 Trials Results of APP13007 for the Treatment after Cataract Surgery at ARVO 2022 Annual Meeting
TAIPEI, April 28, 2022 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. (TWO.6838
2022-04-28 20:00
2393
HanAll Biopharma Reports First Quarter 2022 Results and Provides Business Update
* HanAll will expand R&D investments to advance its late-stage pipeline assets SEOUL, South Korea, April 28, 2022 /PRNewswire/ -- HanAll Biopharma (KRX: 009420.KS), a global biopharma company committed to deliver innovative and impactful therapeutics to address severe unmet medical needs, tod...
2022-04-28 19:00
2463
United Imaging Healthcare bags Healthcare Asia Medtech Award
SHANGHAI, April 28, 2022 /PRNewswire/ -- United Imaging Healthcare was recognised with the Imaging Product Innovation of the Year Award at the Healthcare Asia Medtech Awards with its three groundbreaking products: the Total-body PET/CT uEXPLORER, the 3.0T uMR Omega, and uRT-linac 506c. United Im...
2022-04-28 18:28
5043
Transcenta Announces First Patient Dosed in China Study of Anti-sclerostin Monoclonal Antibody TST002 for the Treatment of Osteoporosis
SUZHOU, China, April 28, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces the successful dosin...
2022-04-28 17:06
3498
The Danish National Genome Center Partners with Lifebit to Deliver Nationwide Personalised Medicine
The Danish National Genome Center has awarded Lifebit a four-year contract to implement Lifebit's Federated Trusted Research Environment software, Lifebit CloudOS, withinDenmark's national supercomputing center. LONDON, April 28, 2022 /PRNewswire/ -- Lifebit, whose leading technology enable...
2022-04-28 14:00
5198
WuXi Biologics' 2021 ESG Report Reveals Company's Strong Commitment to Overall Sustainability
- WuXi Biologics has aligned its ESG strategy with the United Nations Sustainable Development Goals (SDGs), as well as with its stakeholders' interests in sustainable business performance. - One example of WuXi Biologics' contribution to society is its rapid, robust pandemic response -- enab...
2022-04-28 08:30
2789
ASCO 2022 | Ascentage Pharma to Present Data from Seven Clinical Studies at the 2022 American Society of Clinical Oncology Annual Meeting
SUZHOU, China, and ROCKVILLE, MD, April 27, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that updated results from seven studies involving...
2022-04-28 08:18
2361
HealthBeats Raises US$3m Seed Funding Led By Heritas Capital And SEEDS Capital To Expand Remote Vitals Monitoring In Australia And Singapore
SINGAPORE and SYDNEY and NEW YORK, April 28, 2022 /PRNewswire/ -- HealthBeatsTM , aSingapore-based healthtech start-up with end-to-end remote vitals monitoring solution, today announced the close of aUS$3m Seed round led by healthcare investor Heritas Capital together with SEEDS Capital, the inves...
2022-04-28 08:15
3188
CStone to present the latest clinical results of anti-PD-L1 antibody sugemalimab and anti-PD-1 antibody nofazinlimab at ASCO 2022
* Results from GEMSTONE-201 study of sugemalimab, the first successful registrational clinical study to date evaluating an anti-PD-(L)1 antibody targeting patients with relapsed or refractory extranodal natural killer/T-cell lymphoma, will be presented in an oral abstract session * The protoc...
2022-04-28 08:00
4133
Zimmer Biomet's mymobility is recognized as "The Care Management Initiative of the Year" by the 2022 Healthcare Asia Medtech Awards
SINGAPORE, April 28, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that the company's mymobility® digital care management platform won "The Care Management Initiative of the Year" award at this year's Healthcare Asia Med...
2022-04-28 08:00
5766
Glooko Appoints Alfonso "Chito" Zulueta, former Eli Lilly & Company Senior Executive, to Board of Directors
PALO ALTO, Calif., April 28, 2022 /PRNewswire/ -- Glooko, Inc., a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the appointment of Alfonso "Chito" Zulueta to its Board of Directors. Respected as a leader w...
2022-04-28 07:00
4896
3M Petrifilm Plate Reader Advanced wins gold at 2022 Edison Awards
ST. PAUL, Minn., April 27, 2022 /PRNewswire/ -- 3M Food Safety was named a 2022 Edison Awards™ gold winner in the Commercial Technology category for its 3M™ Petrifilm™ Plate Reader Advanced. The Edison Awards globally recognize, honor and foster innovations and innovators whose solutions make a p...
2022-04-27 22:10
2969
China Jo-Jo Drugstores Regains Compliance with Nasdaq Minimum Bid Price Requirement
HANGZHOU, China, April 27, 2022 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced that it ...
2022-04-27 20:30
2337
Alterity Therapeutics Announces Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial in the United Kingdom
MELBOURNE, Australia, April 27, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that the United Kingdom Medicines & Healt...
2022-04-27 19:40
2535
HistoIndex and Global Liver Experts Advance Stain-free AI Quantification of Hepatocyte Ballooning as a Reproducible Approach and Potential Endpoint for NASH Clinical Trials
* This is a first-of-its-kind international study initiated in 2019 by HistoIndex to examine artificial intelligence (AI)-based approaches that may provide a more reliable way to assess the range of injury recorded as "hepatocyte ballooning" as a clinical trial endpoint by expert hepatopatholo...
2022-04-27 17:34
4077
Samsung Biologics Reports First Quarter 2022 Financial Results
* Q1'22 revenue of KRW 511.3 billion increased 96% compared to Q1'21. * Q1'22 operating profit of KRW 176.4 billion increased 137% compared to Q1'21. * Stable business operations and utilization rates across Plants 1, 2, and 3. * Proactive investments into long-term growth, capacity, and su...
2022-04-27 14:42
2670
Zymo Research Makes Strategic Investment in Star Array to Develop an Automated Nucleic Acid Extraction/Superfast PCR Platform for the POCT Market
IRVINE, Calif., April 27, 2022 /PRNewswire/ -- Zymo Research and Star Array today announced Zymo Research's strategic investment to acquire an interest in Star Array, a privately owned, biomedical technology company based inSingapore. The investment allows Zymo Research and Star Array to combine ...
2022-04-27 11:00
4719
RVAC Medicines, a CBC-Incubated mRNA Platform Company, Raises US$140 Million to Expand R&D and Manufacturing Capacity
Series B financing led by CBC with participation from Temasek's Pavilion Capital, EDBI and GS Holdings RVAC plans to build R&D center and manufacturing facilities in Singapore and China SINGAPORE, April 26, 2022 /PRNewswire/ -- RVAC Medicines Pte. Ltd. ("RVAC"), an emerging messenger RNA (mRNA)...
2022-04-27 10:00
3155
Antengene Announces Submission to the Human Research Ethics Committee in Australia for a Phase I Trial of ATG-018
* Developed in-house by internal R&D Team at Antengene, ATG-018 is an orally-available, small molecule ATR inhibitor that targets DNA Damage Response (DDR) pathways. * The Phase I study will evaluate the safety, pharmacology and preliminary efficacy of ATG-018 in patients with advanced solid ...
2022-04-27 08:30
3178
VISTA Eye Specialist (VISTA) Opens its 12th Outlet with Massive Success
PETALING JAYA, Malaysia, April 27, 2022 /PRNewswire/ -- VISTA officially opened
inMalaysia's 5th largest city - Ipoh, marking its 12th outlet in the country.
It presently has seven branches in Klang Valley, three inPenang (Northern
Malaysia) and one in Johor Bahru (Southern Malaysia).
2022-04-27 08:00
4302
Week's Top Stories
Most Reposted
OceanaGold Reports Third Quarter 2026 Results
[Picked up by 1141 media titles]
2026-11-05 06:52Royal Bank of Canada announces agreement to acquire Yarra Capital Management
[Picked up by 1141 media titles]
2026-11-09 21:00Algolia Powers Orange with AI Agents for Billing Support: NYSE Content Update
[Picked up by 1121 media titles]
2026-11-06 22:06
Cision Report Reveals the Consumer Trends Hidden Between Search, Social, and AI
[Picked up by 1105 media titles]
2026-11-09 23:00
Overstory Launches Integrated AI Platform to Deliver First Living Model of Grid Risk
[Picked up by 1083 media titles]
2026-11-03 22:00Most Read
Home Companion Robot Mobo to Debut Globally and Open Pre-orders as AiMOGA Showcases Its Robot Family at the 2026 OMODA & JAECOO International User Summit
2026-11-07 13:49
26162
ZD Energy Unveils Overseas Smart Energy Solutions in Thailand, Leveraging Local Manufacturing and Scenario-Based Capabilities to Support the Country's Energy Transition
2026-11-06 22:12
15075
SILVERSEA MARKS HISTORIC OPENING OF THE CORMORANT AT 55 SOUTH, THE SOUTHERNMOST HOTEL ON EARTH, OFFERING A NEW GATEWAY TO ANTARCTICA
2026-11-07 01:05
14557
OceanaGold Reports Third Quarter 2026 Results
2026-11-05 06:52
14412